CytoMed Therapeutics (FRA:F98) FCF Yield % : -11.22 (As of May. 30, 2024)

View and export this data going back to 2023. Start your Free Trial

What is CytoMed Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CytoMed Therapeutics's Trailing 12-Month Free Cash Flow is €-2.40 Mil, and Market Cap is €21.37 Mil. Therefore, CytoMed Therapeutics's FCF Yield % for today is -11.22%.

The historical rank and industry rank for CytoMed Therapeutics's FCF Yield % or its related term are showing as below:

FRA:F98' s FCF Yield % Range Over the Past 10 Years
Min: -11.22 Med: 0 Max: 0
Current: -11.22

FRA:F98's FCF Yield % is ranked better than
55.83% of 1551 companies
in the Biotechnology industry
Industry Median: -14.39 vs FRA:F98: -11.22

CytoMed Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

CytoMed Therapeutics FCF Yield % Historical Data

The historical data trend for CytoMed Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoMed Therapeutics FCF Yield % Chart

CytoMed Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-7.29

CytoMed Therapeutics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-6.01

Competitive Comparison of CytoMed Therapeutics's FCF Yield %

For the Biotechnology subindustry, CytoMed Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CytoMed Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CytoMed Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CytoMed Therapeutics's FCF Yield % falls into.

CytoMed Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CytoMed Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2.403	/	32.973798
	=	-7.29%

CytoMed Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.991	*	2	/	32.973798
	=	-6.01%

CytoMed Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

CytoMed Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of CytoMed Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

CytoMed Therapeutics (FRA:F98) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CytoMed Therapeutics Ltd (FRA:F98) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GDTC:USA

Address

1 Commonwealth Lane, No. 08-22 One Commonwealth, Singapore, SGP, 149544

Website

https://w2.cytomed.sg

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is majority revenue generator.

CytoMed Therapeutics (FRA:F98) Headlines

No Headlines